DJIA 17,098.45 18.88 0.11%
NASDAQ 4,580.27 22.58 0.50%
S&P 500 2,003.37 6.63 0.33%
market minute promo

company name or ticker

First Pacific Advisors' Top New Buys

3 Pharmaceutical Companies Seeing Insider Buys In Last 30 Days

Nektar Phase III Trials At Risk

Why Nektar Therapeutics May Be About to Take Off

Don't just ask, "How much inventory?" Ask, "What kind?"

Here's What Seth Klarman Is Buying

See what the smartest investors have been up to.

Biotech Analysts See Buying Opportunities From Sell-Off

We compiled a list of biotech companies that have underperformed the S&P 500 over the last month but maintain a solid list of fundamentals.

Biotech Bargains: Biotech Analysts See Buying Opportunities From Selloff

7 Biotechs Near 52-Week Lows

Trolling the bottom for upside potential.

UPDATE: Forest Labs Discloses Icahn Attempt At Board Shakeup

Top Biotech Picks by Hedge Fund and Mutual Fund Gurus Concentrated in the Sector

See More Articles...